Regencell Bioscience Holdings Ltd (RGC)’s stock has witnessed a price hike of 355.41% from the previous close with its current price standing at $71.32. Its current price is 185.28% under its 52-week high of $25.00 and 89344.22% more than its 52-week low of $0.08.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, RGC’s SMA-200 is $2.45.
RGC’s price to book ratio for the most recent quarter was 4291.08, resulting in an 4430.52 price to cash per share for the period.
How does Regencell Bioscience Holdings Ltd (RGC) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 12 brokerage firms that recommend the stock as a Hold. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 3.17 in simple terms.
Regencell Bioscience Holdings Ltd (RGC): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 6 different analysts, who are expecting earnings to fall in between the range of 0.39 and 0.30 with an average Earnings Estimate of 0.34 which is in contrast with the last year earnings estimate of 0.33 and also replicates 3.03% growth rate year over year.
An overview of Regencell Bioscience Holdings Ltd’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Regencell Bioscience Holdings Ltd (RGC) traded 1,233,558 shares per day, with a moving average of $18.14 and price change of +56.75. With the moving average of $9.18 and a price change of +66.45, about 3,112,383 shares changed hands on average over the past 50 days. Finally, RGC’s 100-day average volume is 17,143,867 shares, alongside a moving average of $4.76 and a price change of +66.96.
